# Bioprocess analytics & PAT (process analytical technology) In-line sensing, chromatography and mass spectrometry that turn biomanufacturing into data-driven, feedback-controlled production — a stack from probe to real-time release. Source: https://en.bioecon.ru/technology/bioprocess-analytics-pat/ Updated: 2026-08-18 ## Overview and value chain Markers: [EC: ICH Q8/Q10 QbD & EU GMP Annex 11 | OECD: Bio-pharma | Regulator: FDA (USA), EMA (EU), NMPA (China)] Process analytical technology (PAT) instruments a bioprocess so quality is measured and controlled in real time rather than inferred from end-of-batch testing. In-line Raman, near-IR and UV probes feed multivariate models that predict critical quality attributes (CQAs), closing the loop between sensor and control. The payoff is concrete: continuous Raman feedback in upstream culture can raise monoclonal-antibody titer by around 10% and cut glycation by up to 60% versus intermittent sampling, while continuous chromatography downstream can reduce buffer use by about 40%. The same data backbone — chromatography, high-resolution mass spectrometry and chemometrics — underpins real-time release testing, which compresses batch disposition from days toward a single shift. PAT is encouraged, not mandated, by regulators as the operational core of Quality-by-Design. Key directions of bioprocess analytics & PAT: 1. **In-line Raman process analytics (Raman Process Analytics):** single-use probes track glucose, lactate and titer in real time, enabling automated feedback control. 2. **Continuous chromatography (Continuous Chromatography):** multi-column periodic counter-current purification at steady state, cutting buffer use about 40% versus batch. 3. **Process mass spectrometry and LC (Mass Spec & LC):** high-resolution Orbitrap MS and UPLC for protein characterization and impurity profiling. 4. **Process orchestration and MES/SCADA (Process Orchestration):** multivariate analysis, digital twins and real-time release tying instruments into one control system. ### Sectoral value chain ``` [sampling] ──> [in-line sensing] ──> [CQA modeling] ──> [process control] │ (CQAs + feedback) │ ▼ [real-time release] <─── [QC analytics] <─────┘ ``` ### Value chain levels | Level | Description | Key inputs/outputs | |:---|:---|:---| | **Sampling & Sensing** | in-line / at-line probes on the process | **In:** bioreactor stream. **Out:** raw spectra/signals. | | **Signal Processing** | chemometric baseline and noise reduction | **In:** raw spectra. **Out:** clean signals. | | **CQA Modeling** | multivariate models map signals to attributes | **In:** signals, reference data. **Out:** predicted CQAs. | | **Process Control** | feedback/feed-forward to feeds and columns | **In:** predicted CQAs. **Out:** control actions. | | **QC Analytics** | chromatography, MS, CE release testing | **In:** samples. **Out:** identity/purity data. | | **Real-Time Release** | RTRT batch disposition | **In:** release data. **Out:** certified batch. | Cross-cutting technologies of the sector: - **Chemometrics and MVDA (Multivariate Data Analysis):** statistical models turning spectra into attributes. - **Single-use sensor probes (Single-Use Probes):** gamma-sterilizable in-line optical probes. - **AI quality prediction and digital twins (AI Quality Prediction):** machine-learning models for feed-forward control. --- ## US The US anchors PAT regulation through the FDA's PAT initiative and leads in high-resolution mass spectrometry and continuous chromatography. ### fda pat initiative, high-res mass spec, continuous chromatography - **Cytiva:** the AKTA pcc continuous multi-column chromatography system runs true periodic counter-current purification, cutting buffer use by about 40% versus batch, with UNICORN dimensionless scaling from 1 to 100 mL/min and FDA 21 CFR Part 11 / ISO 13485 compliance. - **Waters Corporation:** its BioResolve Peptide and GTxResolve Lipid columns (230 Å) deliver up to 3x faster GLP-1 characterization and 2x faster LNP analysis, with a global launch from June 2026. - **Thermo Fisher Scientific:** the Orbitrap Tribrid Apex and Excedion mass spectrometers add enhanced dynamic range detecting 3–5x more compounds, paired with AI-enabled BioPharma Finder 5.5 (unveiled at ASMS 2026). --- ## CN China is localizing high-end bioprocess instrumentation, moving from lyophilizers and bioreactors into integrated PAT sensing. ### domestic instrument scale-up, bioreactor PAT, pharma equipment - **Tofflon (300171):** a lyophilizer leader with roughly 60% of China's mid-to-high-end market, now building 10–15,000 L stainless bioreactors with PAT sensors; it reported about 5.23 billion yuan of 2025 revenue and leads an MIIT high-performance-bioreactor project (30 IP filings, 5 patents). - **Truking (Chutian Technology):** a pharma-equipment maker that posted about 5.76 billion yuan of 2025 revenue with net profit up 156% to roughly 255 million yuan, and 2.4% revenue growth in Q1 2026. - **National localization:** the MIIT bioreactor initiative pairs Tofflon with Jiangnan University and CAS Shanghai Microsystems to develop domestic in-situ PAT sensors and mass-transfer components. --- ## EU The EU leads on in-line Raman PAT and the Quality-by-Design standards that frame its adoption. ### raman pat leadership, qbd standards, process spectroscopy - **Sartorius:** in-line Raman PAT and bioprocess analytics for upstream feedback control of glucose and lactate and for downstream UF/DF endpoint determination. - **Mettler-Toledo:** ReactRaman and ReactIR process analytics for in-line reaction and bioprocess monitoring with chemometric modeling. - **QbD and PAT framing:** continuous Raman aligns with ICH Quality-by-Design and real-time quality assurance, which agencies encourage as modern manufacturing practice. --- ## Leading companies and research institutes | Company / Institute | Country | Key products / platforms | Tech features | Status 2026 | |:---|:---|:---|:---|:---| | **Sartorius** | 🇩🇪 Germany | *BioPAT Raman analytics* | in-line upstream/downstream PAT | Commercial | | **Mettler-Toledo** | 🇨🇭 Switzerland | *ReactRaman / ReactIR* | in-line reaction analytics | Commercial | | **Waters Corporation** | 🇺🇸 USA | *BioResolve / GTxResolve* | 3x faster GLP-1 columns | Commercial | | **Cytiva** | 🇺🇸 USA | *AKTA pcc* | continuous chromatography, -40% buffer | Commercial | | **Thermo Fisher Scientific** | 🇺🇸 USA | *Orbitrap Excedion MS* | high-res MS, 3–5x compounds | Commercial | | **Tofflon** | 🇨🇳 China | *PAT bioreactors & lyophilizers* | 10–15,000 L, in-situ sensors | Commercial | --- ## Tech stack and innovations The stack layers in-line spectroscopy, continuous purification and high-resolution analytics. 1. **In-line Raman and spectroscopy (Raman Spectroscopy):** - single-use Raman probes monitor glucose, lactate and titer in real time. - continuous Raman feedback can raise mAb titer about 10% and cut glycation up to 60% versus intermittent sampling. 2. **Continuous multi-column chromatography (Periodic Counter-Current):** - Cytiva's AKTA pcc runs steady-state PCC across columns, using about 40% less buffer than batch. - UNICORN dimensionless scaling translates methods from 1 to 100 mL/min without re-optimization. 3. **High-resolution mass spectrometry (Orbitrap MS):** - Thermo Fisher's Orbitrap Excedion adds enhanced dynamic range, detecting 3–5x more compounds. - BioPharma Finder 5.5 accelerates top-down protein characterization. --- ## Value chains and production pipelines ### Industrial pipeline of real-time release on a continuous train (ICH Q8/Q10) ``` ┌───────────────────────────┐ ┌───────────────────────────┐ │ 1. In-line sampling │ ───> │ 2. Spectral preprocessing │ └───────────────────────────┘ └───────────────────────────┘ │ ▼ ┌───────────────────────────┐ ┌───────────────────────────┐ │ 4. Feedback control │ <─── │ 3. CQA prediction │ └───────────────────────────┘ └───────────────────────────┘ │ ▼ ┌───────────────────────────┐ ┌───────────────────────────┐ │ 5. QC analytics │ ───> │ 6. Real-time release │ └───────────────────────────┘ └───────────────────────────┘ ``` #### Stage 1: In-line sampling Single-use Raman, NIR and UV probes draw continuous spectra directly from the bioreactor and purification streams. #### Stage 2: Spectral preprocessing Chemometric baseline correction and noise reduction clean the raw signals for modeling. #### Stage 3: CQA prediction Multivariate models convert the spectra into critical quality attributes such as titer, glycation and aggregate levels. #### Stage 4: Feedback control Automated feed and column adjustments hold the predicted CQAs within their design ranges. #### Stage 5: QC analytics Liquid chromatography, high-resolution mass spectrometry and capillary electrophoresis confirm identity, purity and impurities. #### Stage 6: Real-time release Real-time release testing dispositions the batch under 21 CFR Part 11 data-integrity controls.